LLY logo

Eli Lilly and Company (LLY) EBIT

annual EBIT:

$17.04B+$10.00B(+142.03%)
December 31, 2024

Summary

  • As of today (April 15, 2025), LLY annual earnings before interest & taxes is $17.04 billion, with the most recent change of +$10.00 billion (+142.03%) on December 31, 2024.
  • During the last 3 years, LLY annual EBIT has risen by +$10.54 billion (+162.34%).
  • LLY annual EBIT is now at all-time high.

Performance

LLY EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

quarterly EBIT:

$5.68B+$3.90B(+219.02%)
December 31, 2024

Summary

  • As of today (April 15, 2025), LLY quarterly earnings before interest & taxes is $5.68 billion, with the most recent change of +$3.90 billion (+219.02%) on December 31, 2024.
  • Over the past year, LLY quarterly EBIT has increased by +$3.04 billion (+114.66%).
  • LLY quarterly EBIT is now at all-time high.

Performance

LLY quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

TTM EBIT:

$13.88B+$3.04B(+27.99%)
December 31, 2024

Summary

  • As of today (April 15, 2025), LLY TTM earnings before interest & taxes is $13.88 billion, with the most recent change of +$3.04 billion (+27.99%) on December 31, 2024.
  • Over the past year, LLY TTM EBIT has increased by +$6.84 billion (+97.14%).
  • LLY TTM EBIT is now at all-time high.

Performance

LLY TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

LLY EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+142.0%+114.7%+97.1%
3 y3 years+162.3%+248.1%+109.3%
5 y5 years+200.7%+248.1%+109.3%

LLY EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+162.3%at high+929.7%at high+111.5%
5 y5-yearat high+200.7%at high+929.7%at high+113.7%
alltimeall timeat high+1678.8%at high+274.5%at high+1386.0%

Eli Lilly and Company EBIT History

DateAnnualQuarterlyTTM
Dec 2024
$17.04B(+142.0%)
$5.68B(+219.0%)
$13.88B(+28.0%)
Sep 2024
-
$1.78B(-51.9%)
$10.84B(+12.8%)
Jun 2024
-
$3.70B(+36.3%)
$9.62B(+18.4%)
Mar 2024
-
$2.72B(+2.6%)
$8.12B(+15.4%)
Dec 2023
$7.04B(-1.4%)
$2.65B(+379.7%)
$7.04B(+7.1%)
Sep 2023
-
$551.80M(-75.0%)
$6.57B(-14.3%)
Jun 2023
-
$2.21B(+35.3%)
$7.67B(+15.6%)
Mar 2023
-
$1.63B(-25.1%)
$6.63B(-7.1%)
Dec 2022
$7.14B(+9.9%)
$2.18B(+32.4%)
$7.14B(+3.8%)
Sep 2022
-
$1.65B(+40.5%)
$6.88B(+4.8%)
Jun 2022
-
$1.17B(-45.2%)
$6.56B(-7.2%)
Mar 2022
-
$2.14B(+11.3%)
$7.07B(+8.8%)
Dec 2021
$6.50B(-14.4%)
$1.92B(+44.6%)
$6.50B(-8.9%)
Sep 2021
-
$1.33B(-20.9%)
$7.13B(-2.7%)
Jun 2021
-
$1.68B(+7.5%)
$7.33B(-0.7%)
Mar 2021
-
$1.56B(-38.9%)
$7.38B(-2.7%)
Dec 2020
$7.59B(+33.9%)
$2.56B(+67.6%)
$7.59B(+11.8%)
Sep 2020
-
$1.53B(-11.8%)
$6.79B(+0.2%)
Jun 2020
-
$1.73B(-2.3%)
$6.78B(+2.3%)
Mar 2020
-
$1.77B(+0.8%)
$6.62B(+16.8%)
Dec 2019
$5.67B(+44.5%)
$1.76B(+16.2%)
$5.67B(+15.7%)
Sep 2019
-
$1.51B(-4.0%)
$4.90B(+2.3%)
Jun 2019
-
$1.58B(+92.9%)
$4.79B(+44.4%)
Mar 2019
-
$817.60M(-17.3%)
$3.31B(-15.5%)
Dec 2018
$3.92B(+55.1%)
$988.80M(-29.5%)
$3.92B(+15.8%)
Sep 2018
-
$1.40B(+1235.1%)
$3.39B(+28.4%)
Jun 2018
-
$105.00M(-92.6%)
$2.64B(-31.4%)
Mar 2018
-
$1.43B(+214.0%)
$3.85B(+52.1%)
Dec 2017
$2.53B(-28.9%)
$454.40M(-30.5%)
$2.53B(-16.2%)
Sep 2017
-
$653.50M(-50.3%)
$3.02B(-10.8%)
Jun 2017
-
$1.31B(+1119.0%)
$3.38B(+10.7%)
Mar 2017
-
$107.80M(-88.6%)
$3.06B(-14.1%)
Dec 2016
$3.56B(+20.6%)
$943.40M(-7.3%)
$3.56B(+14.6%)
Sep 2016
-
$1.02B(+3.1%)
$3.10B(-2.2%)
Jun 2016
-
$987.70M(+61.9%)
$3.17B(+9.3%)
Mar 2016
-
$610.20M(+24.8%)
$2.90B(-1.6%)
Dec 2015
$2.95B(-6.3%)
$488.80M(-55.0%)
$2.95B(-2.1%)
Sep 2015
-
$1.09B(+51.7%)
$3.01B(+15.0%)
Jun 2015
-
$716.50M(+8.8%)
$2.62B(-9.0%)
Mar 2015
-
$658.80M(+19.6%)
$2.88B(-8.6%)
Dec 2014
$3.15B(-47.9%)
$551.00M(-20.6%)
$3.15B(-11.2%)
Sep 2014
-
$693.60M(-28.9%)
$3.55B(-19.5%)
Jun 2014
-
$975.90M(+5.1%)
$4.41B(-11.6%)
Mar 2014
-
$928.60M(-2.2%)
$4.99B(-17.6%)
Dec 2013
$6.05B(+8.3%)
$949.60M(-38.9%)
$6.05B(-1.7%)
Sep 2013
-
$1.55B(-0.1%)
$6.15B(-5.6%)
Jun 2013
-
$1.56B(-21.9%)
$6.52B(+5.3%)
Mar 2013
-
$1.99B(+88.8%)
$6.20B(+10.9%)
Dec 2012
$5.59B(+0.9%)
$1.05B(-45.1%)
$5.59B(-0.7%)
Sep 2012
-
$1.92B(+56.4%)
$5.62B(+7.1%)
Jun 2012
-
$1.23B(-11.0%)
$5.25B(-6.2%)
Mar 2012
-
$1.38B(+26.4%)
$5.60B(+1.1%)
Dec 2011
$5.54B(-17.5%)
$1.09B(-29.4%)
$5.54B(-6.1%)
Sep 2011
-
$1.55B(-1.8%)
$5.90B(-2.8%)
Jun 2011
-
$1.58B(+19.5%)
$6.07B(-3.3%)
Mar 2011
-
$1.32B(-9.2%)
$6.28B(-6.5%)
Dec 2010
$6.71B(+19.4%)
$1.45B(-15.5%)
$6.71B(+4.1%)
Sep 2010
-
$1.72B(-3.7%)
$6.45B(+10.1%)
Jun 2010
-
$1.78B(+1.6%)
$5.86B(+4.5%)
Mar 2010
-
$1.76B(+47.8%)
$5.60B(-0.3%)
Dec 2009
$5.62B(-620.6%)
$1.19B(+5.2%)
$5.62B(+377.7%)
Sep 2009
-
$1.13B(-26.3%)
$1.18B(-932.4%)
Jun 2009
-
$1.53B(-13.5%)
-$141.30M(-66.7%)
Mar 2009
-
$1.77B(-154.4%)
-$424.40M(-60.7%)
Dec 2008
-$1.08B(-122.5%)
-$3.26B(+1624.3%)
-$1.08B(-131.9%)
Sep 2008
-
-$188.80M(-115.1%)
$3.38B(-29.2%)
Jun 2008
-
$1.25B(+11.9%)
$4.78B(-0.1%)
Mar 2008
-
$1.12B(-7.6%)
$4.79B(-0.3%)
Dec 2007
$4.80B(+16.4%)
$1.21B(-0.2%)
$4.80B(+3.2%)
Sep 2007
-
$1.21B(-3.4%)
$4.65B(+3.6%)
Jun 2007
-
$1.25B(+10.6%)
$4.49B(+6.1%)
Mar 2007
-
$1.13B(+7.1%)
$4.23B(+2.6%)
Dec 2006
$4.13B(+13.1%)
$1.06B(+0.7%)
$4.13B(+1.9%)
Sep 2006
-
$1.05B(+5.7%)
$4.05B(+3.0%)
Jun 2006
-
$993.60M(-3.0%)
$3.93B(+2.8%)
Mar 2006
-
$1.02B(+4.4%)
$3.83B(+4.9%)
Dec 2005
$3.65B(-0.3%)
$981.40M(+5.1%)
$3.65B(+0.2%)
Sep 2005
-
$933.50M(+5.1%)
$3.64B(+2.0%)
Jun 2005
-
$887.90M(+5.0%)
$3.57B(-0.5%)
Mar 2005
-
$845.80M(-13.2%)
$3.59B(-1.9%)
Dec 2004
$3.66B
$974.90M(+12.9%)
$3.66B(+2.4%)
Sep 2004
-
$863.60M(-4.6%)
$3.57B(-1.8%)
DateAnnualQuarterlyTTM
Jun 2004
-
$905.50M(-1.0%)
$3.64B(+1.3%)
Mar 2004
-
$914.70M(+2.8%)
$3.59B(+2.6%)
Dec 2003
$3.50B(+5.2%)
$889.80M(-4.2%)
$3.50B(-0.1%)
Sep 2003
-
$928.60M(+8.1%)
$3.50B(+1.0%)
Jun 2003
-
$859.40M(+4.3%)
$3.47B(+2.1%)
Mar 2003
-
$824.00M(-7.7%)
$3.40B(+2.2%)
Dec 2002
$3.33B(-10.8%)
$892.70M(-0.2%)
$3.33B(+3.2%)
Sep 2002
-
$894.50M(+13.3%)
$3.22B(+0.0%)
Jun 2002
-
$789.60M(+5.2%)
$3.22B(-7.4%)
Mar 2002
-
$750.90M(-4.9%)
$3.48B(-6.7%)
Dec 2001
$3.73B(+4.8%)
$789.60M(-11.6%)
$3.73B(-3.5%)
Sep 2001
-
$893.50M(-14.7%)
$3.86B(-3.1%)
Jun 2001
-
$1.05B(+4.9%)
$3.99B(+5.9%)
Mar 2001
-
$999.00M(+8.2%)
$3.76B(+5.7%)
Dec 2000
$3.56B(+5.8%)
$923.10M(-9.1%)
$3.56B(-1.3%)
Sep 2000
-
$1.02B(+23.0%)
$3.61B(+3.4%)
Jun 2000
-
$825.60M(+3.8%)
$3.49B(+2.5%)
Mar 2000
-
$795.60M(-17.9%)
$3.40B(+1.2%)
Dec 1999
$3.36B(+19.1%)
$969.50M(+8.0%)
$3.36B(+7.9%)
Sep 1999
-
$897.70M(+21.2%)
$3.12B(+4.8%)
Jun 1999
-
$740.40M(-2.1%)
$2.98B(+4.1%)
Mar 1999
-
$756.10M(+4.6%)
$2.86B(+1.2%)
Dec 1998
$2.82B(+15.8%)
$722.70M(-4.4%)
$2.82B(+3.8%)
Sep 1998
-
$756.20M(+21.5%)
$2.72B(+4.5%)
Jun 1998
-
$622.30M(-14.0%)
$2.60B(+3.2%)
Mar 1998
-
$723.30M(+16.8%)
$2.52B(+3.5%)
Dec 1997
$2.44B(+19.3%)
$619.40M(-3.2%)
$2.44B(+3.5%)
Sep 1997
-
$639.70M(+18.4%)
$2.36B(+4.5%)
Jun 1997
-
$540.50M(-15.4%)
$2.25B(+4.6%)
Mar 1997
-
$638.80M(+19.0%)
$2.15B(+5.4%)
Dec 1996
$2.04B(+3.2%)
$537.00M(-0.0%)
$2.04B(+4.2%)
Sep 1996
-
$537.20M(+21.9%)
$1.96B(+1.5%)
Jun 1996
-
$440.80M(-16.7%)
$1.93B(-0.9%)
Mar 1996
-
$529.30M(+16.4%)
$1.95B(-1.6%)
Dec 1995
$1.98B(+10.4%)
$454.80M(-10.4%)
$1.98B(+9.8%)
Sep 1995
-
$507.50M(+10.7%)
$1.81B(-0.9%)
Jun 1995
-
$458.60M(-18.2%)
$1.82B(-0.9%)
Mar 1995
-
$560.90M(+101.4%)
$1.84B(+2.4%)
Dec 1994
$1.79B(+175.0%)
$278.50M(-46.8%)
$1.79B(+126.9%)
Sep 1994
-
$523.50M(+10.2%)
$790.90M(+16.2%)
Jun 1994
-
$475.10M(-8.2%)
$680.50M(+2.8%)
Mar 1994
-
$517.80M(-171.4%)
$662.10M(+1.5%)
Dec 1993
$652.60M(-43.5%)
-$725.50M(-275.6%)
$652.60M(-64.2%)
Sep 1993
-
$413.10M(-9.5%)
$1.82B(+65.3%)
Jun 1993
-
$456.70M(-10.2%)
$1.10B(+1.8%)
Mar 1993
-
$508.30M(+14.1%)
$1.08B(-6.2%)
Dec 1992
$1.16B(-34.7%)
$445.30M(-244.9%)
$1.16B(+1.1%)
Sep 1992
-
-$307.40M(-170.3%)
$1.14B(-38.5%)
Jun 1992
-
$437.50M(-24.6%)
$1.86B(+0.4%)
Mar 1992
-
$580.10M(+33.9%)
$1.85B(+4.8%)
Dec 1991
$1.77B(+14.9%)
$433.20M(+5.9%)
$1.77B(+2.8%)
Sep 1991
-
$409.00M(-5.0%)
$1.72B(+2.5%)
Jun 1991
-
$430.30M(-13.2%)
$1.68B(+4.5%)
Mar 1991
-
$495.80M(+28.7%)
$1.61B(+4.3%)
Dec 1990
$1.54B(+32.2%)
$385.30M(+5.2%)
$1.54B(+12.7%)
Sep 1990
-
$366.40M(+2.5%)
$1.37B(+9.2%)
Jun 1990
-
$357.60M(-16.9%)
$1.25B(+4.7%)
Mar 1990
-
$430.10M(+103.5%)
$1.19B(-40.0%)
Dec 1989
$1.16B(+11.3%)
$211.30M(-15.9%)
$1.99B(-1077.6%)
Sep 1989
-
$251.20M(-16.5%)
-$203.40M(-141.9%)
Jun 1989
-
$301.00M(-75.4%)
$486.00M(-59.5%)
Mar 1989
-
$1.23B(-161.8%)
$1.20B(+14.6%)
Dec 1988
$1.05B(+75.9%)
-$1.98B(-310.6%)
$1.05B(+78.0%)
Sep 1988
-
$940.60M(-7.3%)
$588.10M(-2.8%)
Jun 1988
-
$1.01B(-5.4%)
$605.20M(-0.5%)
Mar 1988
-
$1.07B(-144.0%)
$608.10M(+2.2%)
Dec 1987
$595.00M(-30.8%)
-$2.44B(-354.7%)
$595.00M(-48.0%)
Sep 1987
-
$957.70M(-5.9%)
$1.14B(+6.9%)
Jun 1987
-
$1.02B(-3.9%)
$1.07B(+14.9%)
Mar 1987
-
$1.06B(-156.0%)
$931.00M(+8.2%)
Dec 1986
$860.30M(+12.5%)
-$1.89B(-314.0%)
$860.30M(-19.0%)
Sep 1986
-
$883.40M(+0.5%)
$1.06B(+9.9%)
Jun 1986
-
$879.30M(-11.0%)
$966.30M(+14.5%)
Mar 1986
-
$988.30M(-158.5%)
$843.80M(+10.4%)
Dec 1985
$764.40M(+2.7%)
-$1.69B(-314.4%)
$764.30M(-11.8%)
Sep 1985
-
$787.90M(+4.1%)
$866.50M(+9.5%)
Jun 1985
-
$756.80M(-16.7%)
$791.20M(+4.3%)
Mar 1985
-
$908.80M(-157.3%)
$758.30M(+1.9%)
Dec 1984
$744.30M
-$1.59B(-322.7%)
$744.30M(-68.1%)
Sep 1984
-
$712.60M(-1.6%)
$2.33B(+44.0%)
Jun 1984
-
$723.90M(-19.1%)
$1.62B(+80.9%)
Mar 1984
-
$894.80M
$894.80M

FAQ

  • What is Eli Lilly and Company annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Eli Lilly and Company?
  • What is Eli Lilly and Company annual EBIT year-on-year change?
  • What is Eli Lilly and Company quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly EBIT year-on-year change?
  • What is Eli Lilly and Company TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Eli Lilly and Company?
  • What is Eli Lilly and Company TTM EBIT year-on-year change?

What is Eli Lilly and Company annual earnings before interest & taxes?

The current annual EBIT of LLY is $17.04B

What is the all time high annual EBIT for Eli Lilly and Company?

Eli Lilly and Company all-time high annual earnings before interest & taxes is $17.04B

What is Eli Lilly and Company annual EBIT year-on-year change?

Over the past year, LLY annual earnings before interest & taxes has changed by +$10.00B (+142.03%)

What is Eli Lilly and Company quarterly earnings before interest & taxes?

The current quarterly EBIT of LLY is $5.68B

What is the all time high quarterly EBIT for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly earnings before interest & taxes is $5.68B

What is Eli Lilly and Company quarterly EBIT year-on-year change?

Over the past year, LLY quarterly earnings before interest & taxes has changed by +$3.04B (+114.66%)

What is Eli Lilly and Company TTM earnings before interest & taxes?

The current TTM EBIT of LLY is $13.88B

What is the all time high TTM EBIT for Eli Lilly and Company?

Eli Lilly and Company all-time high TTM earnings before interest & taxes is $13.88B

What is Eli Lilly and Company TTM EBIT year-on-year change?

Over the past year, LLY TTM earnings before interest & taxes has changed by +$6.84B (+97.14%)
On this page